REFERENCES
- Maeda N., Tamagawa T., Niki I. et al. Increase in Insulin Release from Rat Pancreatic Islets by Quinolone Antibiotics. Br. J. Pharmacol. 1996; 117(2)372–376
- Tequin. (gatifloxacin) Package Insert. Bristol-Myers Squibb Company, Princeton, NJ Revised May 2002
- Gajjar D.A., LaCreta F.P., Uderman H.D. et al. A Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men. Pharmacotherapy 2000; 20(2)49S–58S
- Gajjar D.A., LaCreta F.P., Kollia G.D. et al. Effect of Multiple-Dose Gatifloxacin or Ciprofloxacin on Glucose Homeostasis and Insulin Production in Patients with Non-insulin Dependent Diabetes Mellitus Maintained with Diet and Exercise. Pharmacotherapy 2000; 20(2)76S–86S
- Grasela D.M., LaCreta F.P., Kollia G.D. et al. Lack of Effect of Multiple Dose Gatifloxacin on Oral Glucose Tolerance, Glucose and Insulin Homeostasis, and Glyburide Pharmacokinetics in Patients with Type II Non-insulin Dependent Diabetes Mellitus.[poster]. 39th Interscience Conference on Antimicrobials and Chemotherapy Meeting, San Franciso, CA, 1999
- Written Communication with Bristol-Myers Squibb, May 7, 2002
- Miki T., Nagashima K., Seino S. The Structure and Function of the ATP-sensitive K+ Channel in Insulin-secreting Pancreatic β-cells. J. Mol. Endocrinol. 1999; 22: 113–123
- Fish D.N. Fluoroquinolone Adverse Effects and Drug Interactions. Pharmacotherapy 2001; 21(2)253S–272S
- Rubenstein E. History of Quinolones and Their Side Effects. Chemotherapy 2001; 47: 44–8, Suppl 3, 3–8; discussion
- Fish D.N., North D.S. Gatifloxacin: An Advanced 8-methoxy-fluoroquinolone. Pharmacotherapy 2001; 21(1)35–59
- Paladino J.A. Is More Than One Quinolone Needed in Clinical Practice?. Annals of Pharmacotherapy 2001; 35(9)1085–1095